Brown-Forman Corporation (BF-A): what the price assumes

In the published model solve dated 2026-Q2, anchored at $27.75, Brown-Forman Corporation (BF-A) is priced for -4.5% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/BF-A

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 7.7% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is justified by relative-multiple; earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.7%); the inversion above states its own rate.

Per-Model Detail (n=15)

Solvency

Bullet Takeaways

• Whiskey supplies 74% of the revenue mix here, so when the fiscal 2026 annual report records that "Net sales for JDTW declined 2%, driven by lower volumes in the United States and our developed international markets, led by Germany, the United Kingdom, and Canada", that is not one brand having a soft year but the core of the business slowing.
• The company has already told investors where fiscal 2027 goes, guiding organic net sales "to be approximately flat" and organic operating income to decline "in the 3% to 5% range", which puts the burden of proof on any argument that the past two years were a passing cycle.
• Return on average invested capital, as the company itself measures it, fell to 11.9% in fiscal 2026 from 14.4% the year before, and the direction of that figure over the next several prints is the cleanest available test of whether price and mix can carry the business while volume stands still.

Bull Case

Ownership is where this business is genuinely unusual, and it is the right place to start with the voting shares. The fiscal 2026 annual report states the position without decoration: "The Brown family has the ability to control the outcome of matters submitted for stockholder approval." The same filing confirms the arrangement has no expiry, noting that "we do not have a sunset provision in our Restated Certificate of Incorporation or By-laws that provides for the eventual reclassification of the non-voting common stock to voting common stock". Governance screens dislike this intensely. Capital allocation is where it earns its keep. A controlling family with a century of tenure does not have to defend a soft two-year stretch to an activist, does not have to manufacture a recovery to protect a compensation cycle, and can let an inventory of aging whiskey sit for the years it needs to sit.

Follow the cash and the picture turns conservative to the point of dullness. Planned capital spending for fiscal 2027 is "in the range of $60 to $70 million", against net sales of $3.9 billion. That is a business nobody has to rebuild, because the expensive asset is barreled whiskey funded in prior years that now simply gets older and more valuable. What is left goes out as dividends and buybacks. The quarterly dividend runs at 23.1 cents a share, and the share count has come down roughly 0.9% a year over the four years to January 2026. Neither figure is dramatic. Both are the sort of thing that compounds while nobody is watching.

The operating evidence for the moat sits in the gross margin line. In a year when net sales slipped 1%, gross profit still "increased $35 million, or 2%, in fiscal 2026 compared to fiscal 2025" and gross margin reached 60.5% of net sales, up 1.6 percentage points. Volume did not produce that. Price and mix did. For scale, Constellation Brands (STZ) discloses a 50.0% gross margin and a 29.9% operating margin, while Molson Coors (TAP) and Boston Beer (SAM) both carried negative operating margins on their own reported figures. Raising price into a soft demand year is the entire argument for owning a spirits brand rather than a beverage manufacturer.

Scale in spirits also means something different from scale in beer. Citing IWSR, the annual report notes that "for calendar year 2025, the ten largest global spirits companies controlled over 20% of the total spirits volume sold around the world". Twenty percent between the ten largest is a remarkably unconcentrated industry by consumer-staples standards, and in a fragmented market the brand that travels is the asset. Jack Daniel's travels. The filing lays out fifteen years of line extensions built off it, from Tennessee Honey in 2011 through the Blackberry launch in fiscal 2026, each one a way to sell more liquid without constructing a new brand from nothing.

Mix is also moving in the direction a brand owner would choose at this point in a cycle. The declines in Jack Daniel's Tennessee Whiskey came from the United States and the mature international markets, and were "partially offset by broad-based volumetric growth across our emerging markets". The bull case does not require the developed markets to come back. It requires the emerging ones to keep going while pricing holds, and fiscal 2026 delivered both.

Bear Case

Erosion in a brand business rarely announces itself. It arrives as a run of small, individually defensible decisions, and the fiscal 2026 disclosures contain several. Advertising expenses "decreased 4% in fiscal 2026, driven by lower spend for the Jack Daniel's family of brands". In that same year, net sales for Jack Daniel's Tennessee Whiskey fell 2% on lower volumes across the United States, Germany, the United Kingdom and Canada. Spending less behind the brand that is losing volume is a reasonable short-term margin choice and a corrosive long-term one, and the filing makes no attempt to dress it up.

Return on capital records the same trend with less room for interpretation. The company reports that "Our return on average invested capital decreased to 11.9% in fiscal 2026, compared to 14.4% in fiscal 2025", attributing the fall to lower operating income and the absence of a prior-year gain on a divested investment. Underneath it sit non-cash impairment charges and fair value adjustments that the filing says "negatively impacted our operating expenses and operating income for fiscal 2025 and 2026", alongside a restructuring plan the Board approved during fiscal 2025. Two consecutive years of write-downs is the accounting system marking assets that were bought when the category grew faster than it does now.

None of which makes the price wrong, and this is exactly where the bear has to be honest. The price is already low against what the company earns: it sits below the level even a 5% a year decline in operating profit would warrant, discounted at a 7.7% cost of capital. Management's own fiscal 2027 guide is an organic operating income decline of 3% to 5%. So the bear thesis is not that a fine business has been overpriced. It is that a 5% annual decline is being treated as a conservative floor when the past two years suggest it is closer to the current run rate. Extend the decline past the one year management has guided and the multiple that looks undemanding today gets applied to a smaller profit each year, which is how a cheap-looking staple stays cheap-looking for a decade.

The external variables are not management's to control either. The annual report warns that consumers "may begin to shift their consumption and purchases away from our premium and super-premium products, or away from alcoholic beverages entirely", which is the courteous phrasing of the demographic question hanging over the whole category. On trade, the filing records that the United States "has announced and/or implemented significant new tariffs on imported goods from a wide range of countries, which has prompted retaliatory tariffs" elsewhere. American whiskey has a long record of being an early target in precisely that kind of exchange, and a company whose signature product is made in one state and sold worldwide has no manufacturing workaround available.

The balance sheet is neither a crisis nor a cushion. Net debt sits near 2.2 billion dollars, the liquid asset balance is thin against it, and the aged-inventory model commits working capital years before it earns anything back. Interest is covered many times over out of operating profit, so solvency is not the question. Flexibility is. A family-controlled company with a falling profit line, a dividend it will not cut, and barrels that have to keep being filled regardless has fewer levers available than the coverage figure alone suggests.

Valuation

Start with what the price has already conceded. Today's level values the whole enterprise at about 11.4 times a year of company-wide operating income, low enough that the price sits below what even a 5% a year decline in operating profit would warrant on a discounted view built at a 7.7% cost of capital over a five-year stage. That is not a growth bet. It is close to the opposite: a price that has pre-agreed to shrinkage.

Management has made the comparison unusually easy. The fiscal 2027 outlook calls for organic net sales "to be approximately flat", organic operating income to decline "in the 3% to 5% range", and an effective tax rate "in the range of approximately 20% to 22%". Line those up and the price is broadly consistent with management's own guided year repeating indefinitely. Whether that constitutes value depends entirely on what year two looks like.

The methods used to triangulate this business disagree, and the shape of the disagreement carries more information than any single one of them. Peer multiples land closest, with the price standing only about 5% above where that family of methods centres. Book value plus profitability, and the forward-growth methods, both centre roughly a third below the price. The earnings-power methods sit furthest away, the price about 68% above that family, because those methods capitalize the cash generated this year and credit no growth whatsoever. The ranking is legible enough: the price is defended by what comparable companies fetch, and it is not defended by this year's cash flow standing alone. Between those two readings sits the only question that matters, which is whether fiscal 2026 was a trough or a new level.

Solvency barely moves the picture, and that is the point. Net debt of about 2.2 billion dollars leaves interest covered many times over from operating profit, and the company is not consuming cash. The share count has drifted down roughly 0.9% a year since January 2022, which is buyback deployment showing up in the one place it cannot be faked. Earnings still came to $1.53 a share on a diluted basis in fiscal 2026, so the dividend is being paid out of profit rather than borrowed.

One comparison is worth closing on, and it is the one the market itself makes every trading day. The non-voting class, BF-B, changes hands near 26.08 dollars while these voting shares fetch $26.70. Slightly over two percent is what a vote is currently worth in a company where the controlling family cannot be outvoted regardless.

Catalysts

Brown-Forman closed its fiscal year on April 30 and reported it on June 4, 2026. Full-year net sales came to $3.9 billion, down 1% as reported and flat on an organic basis, with diluted earnings of $1.53 a share, down 17%. The fourth quarter was the more revealing half of the release: net sales rose 2% to $912 million, while reported operating income fell 53% to $96 million and was flat organically. The distance between the reported and organic figures is the impairment and restructuring activity the annual report describes.

The outlook attached to that release is the operative number for the next four quarters. Management expects organic net sales approximately flat in fiscal 2027, organic operating income lower by 3% to 5%, an effective tax rate of approximately 20% to 22%, and capital expenditures of $60 to $70 million. Read together, that is a company planning to hold volume, protect margin, and spend nothing extraordinary while the category finds its footing.

The street has followed rather than led. Barclays cut its rating to Equal Weight from Overweight on June 25, 2026, one of a cluster of target reductions that arrived after the print and the fiscal 2027 guide. The dividend did not move with the rating: the quarterly payment of 23.1 cents a share went ex on June 10, 2026. For a stock this far into a re-rating, the next real information event is the fiscal first-quarter report, where the question is narrow and answerable. Did the emerging-market volume growth that offset developed-market declines in fiscal 2026 carry into the new year.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• BF-B (Brown-Forman Corporation)
• FY2025 10-K: …competing products. If the buying power of these large retail customers continues to increase, it could negatively affect our financial results. Further, while we believe we have sufficient scale to succeed relative to our major competitors, we nevertheless face a risk that continuing consolidation of large beverage…
• FY2025 10-K: …to distribute our brands, generally under fixed-term distribution contracts. In Canada, we sell our products to provincial governments. We believe that our customer relationships are good and that our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations…
• DEO (DIAGEO plc)
• FY2025 20-F: …organisation. We expect to deliver approximately c.$625 million in cost savings over the next three years through efficiencies in A&P, overheads, supply chain, and trade investment. Around c.50% of these savings are expected to contribute to operating profit, with the remaining c.50% reinvested in growth areas such…
• FY2025 20-F: …of (1.1)%, partially offset by hyperinflation adjustments and organic net sales growth. Organic net sales growth of 1.7% was driven by organic volume growth of 0.9% and positive price/mix of 0.8%. Excluding the impact of the Cîroc transaction, organic net sales growth was 1.5%, with 0.8% volume growth and 0.7%…
• STZ (CONSTELLATION BRANDS, INC.)
• FY2025 10-K: …Officer. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by,…
• FY2025 10-K: …We perform ongoing credit evaluations of our customers' financial position, and management is of the opinion that any risk of significant loss is reduced due to the diversity of our customers and geographic sales area. 22. BUSINESS SEGMENT INFORMATION Our internal management financial reporting consists of two…
• SAM (THE BOSTON BEER COMPANY, INC.)
• FY2025 10-K: …significantly greater resources than the Company. This competitive environment may affect the Company's overall performance within the Beyond beer and Traditional beer categories. As the market continues to consolidate, the Company believes that companies that are well-positioned in terms of brand equity, marketing…
• FY2025 10-K: Company anticipates competition will remain strong as existing beverage companies continue adding more SKUs and styles. The potential for growth in the sales of flavored malt beverages, hard seltzers, domestic beers, imported beers and spirits RTDs is expected to increase the competition in the market for Beyond beer…
• TAP (MOLSON COORS BEVERAGE CO)
• FY2025 10-K: …In the U.S. and Canada, we compete most directly with Anheuser-Busch InBev SA/NV ("ABI") and Constellation Brands, Inc., but we also compete with imports and other providers of craft beer and flavored malt beverages. In the European countries where we currently operate, our primary competitors are Heineken, Asahi,…
• FY2025 10-K: …over the years becoming an increasingly consolidated global beer market. For many years, the industry operated primarily on local presence with modest international expansion achieved through export, license and partnership arrangements. In contrast, it has now become increasingly complex and competitive as the…
• KDP (Keurig Dr Pepper Inc.)
• FY2025 10-K: Financial Statements for additional information on the JDE Peet's Acquisition and related transactions. On August 25, 2025, we announced our intention to separate our beverage and coffee portfolios into two independent, publicly traded companies, which will allow for more tailored growth strategies, operating models,…
• FY2025 10-K: …their route-to-market, reducing prices, or increasing promotional activities. We also compete with various smaller or regional companies and private label manufacturers, which may be more innovative, better able to bring new products to market, and better able to quickly serve niche markets. Additionally, we compete…
• FIZZ (National Beverage Corp.)
• FY2025 10-K: …and our competitive position may vary by market area. Our products compete with many varieties of liquid refreshment, including water products, soft drinks, juices, fruit drinks, energy drinks and sports drinks, as well as powdered drinks, coffees, teas, dairy- based drinks, functional beverages and various other…
• FY2025 10-K: …case volume. The average cost of sales per case remained relatively unchanged and gross margin increased to 37.0% compared to 36.0% for Fiscal 2024. Shipping and handling costs are included in selling, general and administrative expenses, the classification of which is consistent with many beverage companies.…
• MKC (McCORMICK & COMPANY, INCORPORATED)
• FY2025 10-K: 025 as compared to 2024 and increased by 1.9% on an organic basis. Favorable pricing impacted sales by 0.2%. Favorable volume and product mix increased sales by 1.7% driven by higher sales to foodservice customers in China. The unfavorable impact from foreign currency rates decreased sales by 0.9% and is excluded from…
• FY2025 10-K: 5 of the notes to our consolidated financial statements and the "Liquidity and Financial Condition" section of "Management's Discussion and Analysis." Competition Each segment operates in highly competitive markets around the world. In this environment, our growth strategies include customer engagement and product…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.